
Medicare's $50 GLP-1 Drug Benefit Sparks Doctor Bottlenecks
Medicare will cover weight-loss drugs for $50/month from July through 2027, a move that could unleash pent-up demand but strain clinics with prior authorizations and essential counseling, while not covering accompanying nutrition or behavioral support or counting toward out-of-pocket caps; uptake may be limited by existing GLP-1 use and fixed incomes.












